48 Groups Want Trump Administration To Improve Process to Resolve Payer-Provider Disputes
A coalition of employer and consumer groups is urging the Trump administration to crack down…
A coalition of employer and consumer groups is urging the Trump administration to crack down on alleged abuse of the No Surprises Act’s independent dispute resolution process. The post 48 Groups Want Trump Administration To Improve Process to Resolve Payer-Provider Disputes appeared first on MedCity News.
Researchers from UC San Diego, Johns Hopkins and UPMC have developed an AI-powered CPR coaching tool called ChatCPR that outperformed human 911 dispatchers in guiding bystanders through CPR. The team released the tool as an open-source resource, with the hopes that the right companies and emergency-response organizations can deploy it broadly. The post ChatGPT Wants…
AstraZeneca’s Baxfendy is the first FDA-approved drug in a new class of medicines called aldosterone synthase inhibitors. The new mechanism of action is important for patients and for AstraZeneca, which has been looking for new drugs with blockbuster potential as its top cardiometabolic medicine faces patent expiration. The post FDA Approves AstraZeneca Drug With New…
If you are a payer or a policymaker, should you except the results of a global clinical trial or require additional evidence that a drug works in your country. There are a few options to consider. Delay approval until local confirmatory trial. Approach enacted in several Asian countries (see Habr et al. 2024). While this…
This brief compares the prices paid by private insurers for hospital care to increases in Medicare payment using data from the Bureau of Labor Statistics (BLS) Producer Price Index (PPI), finding that hospital prices have risen much faster for private insurance than Medicare since 2019.
Organizations that can generate and apply high-quality, clinically grounded evidence will be better positioned to close the gap between what is proven in trials and what is achieved in practice. The post Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology appeared first on MedCity News.
The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined. The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.
Cost management strategies need to focus on simplifying the system, doing away with the outdated processes that inflate costs, and building and deploying tools that allow organizations to control their spending. The post Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them appeared first on MedCity News.
In the 39 states that are adopting or may adopt the high unemployment hardship exception, about 1.4 million or 7.5% of Medicaid expansion enrollees live in one of the 133 counties that currently meet the high-unemployment criteria.
Overwhelmed by the demands of caregiving, Quette dialed 911 when she found her teenage son downstairs in their kitchen struggling to breathe. He had rolled his wheelchair to the oven to keep himself warm as he tried to regulate his temperature, she recalled, and was drenched in sweat from an apparent infection. In that moment,…